• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(+)-和(-)-3-甲氧基赛庚啶。与赛庚啶相比,对其抗血清素、抗组胺、抗胆碱能和促食欲特性的评估。

(+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine.

作者信息

Remy D C, Rittle K E, Hunt C A, Anderson P S, Engelhardt E L, Clineschmidt B V, Scriabine A

出版信息

J Med Chem. 1977 Dec;20(12):1681-4. doi: 10.1021/jm00222a031.

DOI:10.1021/jm00222a031
PMID:592336
Abstract

The synthesis and resolution of (+/-)-3-methoxycyproheptadine [(+/-)-4] are described. As a peripheral serotonin antagonist, (+/-)-4 was found to be one-half as potent as cyproheptadine (1b). The peripheral anticholinergic and antihistaminic activities as well as the orexigenic property of (+/-)-4 are less than those of 1b. A further comparison of the enantiomers (+)-4 and (-)-4 shows that all of the anticholinergic activity of (+/-)-4 resides solely in the dextrorotatory enantiomer, (+)-4, while the antiserotonin activity, which is similar to that of 1b, resides in the levorotatory enantiomer, (-)-4. Antihistaminic and orexigenic activity also resides in (-)-4 but these properties are reduced compared to those of 1b.

摘要

描述了(+/-)-3-甲氧基赛庚啶[(+/-)-4]的合成与拆分。作为一种外周5-羟色胺拮抗剂,发现(+/-)-4的效力是赛庚啶(1b)的一半。(+/-)-4的外周抗胆碱能和抗组胺活性以及促食欲特性均低于1b。对映体(+)-4和(-)-4的进一步比较表明,(+/-)-4的所有抗胆碱能活性仅存在于右旋对映体(+)-4中,而与1b相似的抗5-羟色胺活性则存在于左旋对映体(-)-4中。抗组胺和促食欲活性也存在于(-)-4中,但与1b相比,这些特性有所降低。

相似文献

1
(+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine.(+)-和(-)-3-甲氧基赛庚啶。与赛庚啶相比,对其抗血清素、抗组胺、抗胆碱能和促食欲特性的评估。
J Med Chem. 1977 Dec;20(12):1681-4. doi: 10.1021/jm00222a031.
2
A comparison of the antiserotonin, antihistamine, and anticholinergic activity of cyproheptadine with analogues having furan nuclei fused to the 10,11-vinylene bridge.将赛庚啶与在10,11-亚乙烯基桥上稠合有呋喃核的类似物的抗血清素、抗组胺和抗胆碱能活性进行比较。
J Med Chem. 1977 Jun;20(6):836-8. doi: 10.1021/jm00216a020.
3
Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadine.3-羧基-10,11-二氢赛庚啶的食欲刺激活性。
Arch Int Pharmacodyn Ther. 1976 Oct;223(2):287-300.
4
Cyproheptadine analogues: synthesis, antiserotoninergic activity, and structure-activity relationships.赛庚啶类似物:合成、抗血清素能活性及构效关系
J Pharm Sci. 1993 Nov;82(11):1090-3. doi: 10.1002/jps.2600821105.
5
Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine.(-)-1-环丙基甲基-4-(3-三氟甲基硫代-5H-二苯并[a,d]环庚烯-5-亚基)哌啶的合成及其立体特异性抗精神病活性
J Med Chem. 1977 Aug;20(8):1013-9. doi: 10.1021/jm00218a005.
6
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.赛庚啶衍生物(+/-)-1-环丙基甲基-4-(3-三氟甲硫基-5H-二苯并[a,d]环庚烯-5-亚基)哌啶(CTC)对映体的立体特异性抗多巴胺能和抗胆碱能作用
J Pharmacol Exp Ther. 1979 Mar;208(3):460-7.
7
[Central action of WA-335-BS, a substance with peripheral antiserotonin and antihistaminic activity].[WA-335-BS的中枢作用,一种具有外周抗血清素和抗组胺活性的物质]
Arzneimittelforschung. 1975 Nov;25(11):1737-44.
8
Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.3-甲氧基赛庚啶在犬冠状动脉血栓形成模型中的作用
J Pharmacol Exp Ther. 1988 Nov;247(2):796-802.
9
N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability.N-取代的11-(4-哌啶撑)-5,6-二氢-11H-苯并-[5,6]环庚并[1,2-b]吡啶。无镇静作用的抗组胺药。
Arzneimittelforschung. 1986 Sep;36(9):1311-4.
10
3-Aroylmethyl-2H-1,3-benzoxazinedione derivatives with anticholinergic and antihistaminic activities.
Farmaco. 1993 Jul;48(7):1015-20.

引用本文的文献

1
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.国际基础与临床药理学联合会。XCVIII.组胺受体。
Pharmacol Rev. 2015 Jul;67(3):601-55. doi: 10.1124/pr.114.010249.
2
Engineering of indole-based tethered biheterocyclic alkaloid meridianin into β-carboline-derived tetracyclic polyheterocycles via amino functionalization/6-endo cationic π-cyclization.通过氨基官能化/6-endo 阳离子 π-环化,将基于吲哚的键合双杂环生物碱子午线工程成β-咔啉衍生的四环多杂环。
Beilstein J Org Chem. 2012;8:1901-8. doi: 10.3762/bjoc.8.220. Epub 2012 Nov 8.
3
A steric approach for the design of antihistamines with low muscarinic receptor antagonism.
一种设计具有低毒蕈碱受体拮抗作用的抗组胺药的空间方法。
Inflamm Res. 1995 Apr;44 Suppl 1:S90-1. doi: 10.1007/BF01674411.